Evidence map›Paper›PMID 41995785›Full record

ArticleDrug safety2026

Correction: Liver Safety of the Dual Neurokinin‑1/‑3 Receptor Antagonist Elinzanetant.

James H Lewis, Raúl J Andrade, Dominique Larrey, Yves Horsmans, Richard A Anderson, Mila Trajanovic, Esther Groettrup-Wolfers, Lineke Zuurman

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

James H LewisDepartment of Gastroenterology and Hepatology, Georgetown University Medical Center, Washington, DC, USA. lewisjh9205@gmail.com.ORCID http://orcid.org/0000-0002-6686-3744
Raúl J AndradeInstituto de Investigación Biomédica de Málaga-IBIMA Plataforma Bionand, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, CIBERehd, Málaga, Spain.ORCID http://orcid.org/0000-0002-1565-0757
Dominique LarreyLiver Unit, Saint-Eloi Hospital, Montpellier School of Medicine, Montpellier, France.ORCID http://orcid.org/0000-0002-0892-3489
Yves HorsmansDepartment of Hepato-Gastroenterology, Cliniques Universitaires Saint-Luc et Institut de Recherche Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium.ORCID http://orcid.org/0000-0002-5779-2454
Richard A AndersonCentre for Reproductive Health, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.ORCID http://orcid.org/0000-0002-7495-518X
Mila TrajanovicBayer US LLC, Whippany, NJ, USA.
Esther Groettrup-WolfersBayer AG, Berlin, Germany.ORCID http://orcid.org/0000-0003-1840-8015
Lineke ZuurmanBayer CC, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41995785
PMCPMC13354655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.